About Exactus
Exactus is a publicly listed company based in Glen Allen (United States) founded in 2008. POC diagnostics for fibrinolytic status assessment are developed. The company has 3 employees. Exactus has completed 2 acquisitions, including Hemp Healthy and LeVor Collection. Exactus offers products and services including DAILY Full Spectrum CBD Softgels, CBD Oil Drops, Cherry Bomb CBD Gummies, Soothe CBD Topical Salve, and Canine CBD Softgels. Its focus areas include Life Sciences, Hematology, In Vitro Diagnostics Tests and Coagulopathies. Its legal entity is EXACTUS, INC. Its competitors include Hemosonics, Stasys and HemoSense; 3 of its 3 listed competitors have raised funding.
Company details
Exactus Diagnostics develops POC diagnostics to assess the fibrinolytic status of patients. The FibriLyzeris a handheld device with disposable test strips that measures levels of proteolytic enzymes in blood to identify patients at risk of hemorrhage using a single drop of blood. Results are available within 30 seconds. It also has a second product in the pipeline MatriLyzer for early detection of cancer, and for monitoring for the recurrence of cancer.
- Headquarters Glen Allen, United States
- Employees 3
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website exactusinc.com
- Legal Name Exactus, Inc.
- Latest Funding Round$2M (USD), Post-IPO
Dec 2019
- Employee Count3
- Investments & AcquisitionsHemp Healthy
& 1 more
Products & Services of Exactus
Exactus offers a comprehensive portfolio of products and services, including DAILY Full Spectrum CBD Softgels, CBD Oil Drops, Cherry Bomb CBD Gummies, Soothe CBD Topical Salve, and Canine CBD Softgels.
Softgels providing daily CBD intake for health support.
Oil drops for sublingual CBD consumption and wellness benefits.
Gummies offering CBD for mood and pain relief purposes.
Salve for targeted pain relief and skin care application.
Softgels designed for pet health and anxiety management.
Funding Insights of Exactus
- Total Rounds 6
- Last Round Post-IPO — $2M
- First Round $100,000
(Dec 2015)
All 6 funding rounds of Exactus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2019 | $2M | Post-IPO | – | – | – |
| Feb 2019 | $1.15M | Post-IPO | – | – | – |
| Jan 2019 | $641,589 | Post-IPO | – | – | – |
| Oct 2016 | $1.5M | Post-IPO | – | – | – |
| Aug 2016 | $125,000 | Post-IPO | – | – | – |
| Dec 2015 | $100,000 | Post-IPO | – | – | – |
Investments & Acquisitions by Exactus
Exactus has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Hemp Healthy and LeVor Collection.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Hemp-based skin care products are offered through an internet-first brand. | levorcollection.com | Coconut Creek, United States | 2019 | Oct 2019 | •••• | |
Vertically integrated hemp company | buyhempcbd.com | Delray Beach, United States | 2014 | Mar 2019 | •••• |
Complete acquisition details for Exactus
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Exactus
6 dated milestones of Exactus across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Exactus is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $100K.
- Acquisition Acquires Hemp Healthy.
- Acquisition Acquires LeVor Collection.
- Funding Latest funding round, Post-IPO, of $2.0M.
Competitors of Exactus
Exactus has 3 listed competitors in our database, 3 of them funded. They include Hemosonics, Stasys and HemoSense.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hemosonics.com | 2004 | Charlottesville, United States | $24.92M | IVD for hemostasis characterization | ||
| stasysmedical.com | 2013 | Seattle, United States | $2.85M | Provider of POC device for analyzing blood clotting disorders and platelet dysfunction | ||
| hemosense.com | 1997 | San Jose, United States | $17.7M | Rapid Point-of-Care Coagulation analyzer |
Detailed competitors of Exactus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hematology
3 companies that operate in the same segment as Exactus (Hematology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | 384 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Exactus
Complete news archive for Exactus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exactus
Exactus was founded in 2008 and raised its 1st funding round 7 years after it was founded.
Exactus is headquartered in Glen Allen, United States. It is registered at Glen Allen, Virginia, United States.
Exactus has 3 employees.
Exactus Diagnostics develops POC diagnostics to assess the fibrinolytic status of patients. The FibriLyzeris a handheld device with disposable test strips that measures levels of proteolytic enzymes in blood to identify patients at risk of hemorrhage using a single drop of blood. Results are available within 30 seconds. It also has a second product in the pipeline MatriLyzer for early detection of cancer, and for monitoring for the recurrence of cancer.
Exactus's top competitors include Hemosonics, Stasys and HemoSense.
Exactus offers DAILY Full Spectrum CBD Softgels, CBD Oil Drops, Cherry Bomb CBD Gummies, Soothe CBD Topical Salve, and Canine CBD Softgels.
Exactus has made 2 acquisitions, including Hemp Healthy, and LeVor Collection.
Exactus operates through Exactus, Inc..